Replacement of valsartan and candesartan by telmisartan in hypertensive patients with type 2 diabetes: metabolic and antiatherogenic consequences.

Miura, Yoshitaka

Replacement of valsartan and candesartan by telmisartan in hypertensive patients with type 2 diabetes: metabolic and antiatherogenic consequences. [electronic resource] - Diabetes care Mar 2005 - 757-8 p. digital

Publication Type: Clinical Trial; Controlled Clinical Trial; Letter

0149-5992

10.2337/diacare.28.3.757 doi


Adult
Aged
Angiotensin II Type 1 Receptor Blockers--therapeutic use
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Benzimidazoles--therapeutic use
Benzoates--therapeutic use
Biphenyl Compounds
Blood Pressure--drug effects
Diabetes Mellitus, Type 2--complications
Diabetic Angiopathies--drug therapy
Female
Humans
Hypertension--drug therapy
Male
Middle Aged
Telmisartan
Tetrazoles--therapeutic use
Valine--analogs & derivatives
Valsartan